Stryker manufactures medical devices and medical equipment. Stryker is a leader in the worldwide orthopaedic medical technology market and is at the forefront of medicine's most promising solutions.
35,623 1% Last mo
Use Stryker's historical employee count to better understand their growth and spending over time.
Unlock with a Free Trial
Use Stryker's historical monthly uniques as a proxy for mindshare and web traction.
Use Stryker's historical Twitter followers and likes to better understand their social media traction over time.
Use Stryker's historical Linkedin followers to better understand their social media traction over time.
Use Stryker's mobile downloads and app ranks to evaluate the performance of their mobile apps.
Unlock Stryker's app download and grossing ranks in the iTunes App Store to understand how well they have done on mobile historically.
Stryker's Trevo® Retriever becomes first and only device indicated for treatment up to 24 hours, aligning with new AHA/ASA guidelines
Analysts at SunTrust Reconfirmed their “Buy” rating for Stryker (NYSE:SYK) with $179.0 Target Price
Stryker's WEAVE Trial demonstrates positive results of endovascular treatment for patients with intracranial atherosclerotic disease
Stryker announces the success of the simplified tender offer for outstanding shares of VEXIM
UPDATE 1-Stryker beefs up ENT business with $662 mln Entellus buy